RECRUITING

Precision Analytic Research Methods in OCD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Psychiatric disorders characterized by compulsivity, such as obsessive-compulsive disorder (OCD), result in considerable functional impairment and many individuals do not respond to gold-standard treatments. Compulsivity has long been thought to occur due to exaggerated habits and reduced goal-directed control, although more recently, this conceptualization of compulsivity as an imbalance of two cognitive systems has been challenged as overly narrow. This study will recruit 100 individuals (50 adults diagnosed with OCD, 50 healthy controls) and leverage the measurement precision offered by theory-driven computational modeling in combination with electroencephalogram (EEG) to go beyond this binary theory of compulsivity, revealing how more complex interactions of neurocognitive subcomponents contribute to compulsivity-information that could ultimately lead to improved treatment personalization and clinical outcomes.

Official Title

Dissecting Neurocognitive Components of Compulsivity Using Computational Modeling and EEG

Quick Facts

Study Start:2025-07-24
Study Completion:2030-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07011901

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * between the ages 18-55 years old
  2. * English-speaking
  3. * right-handed
  4. * able to provide consent
  1. * they meet diagnostic criteria for certain other psychiatric disorders
  2. * are taking psychiatric medication or have received behavioral treatment for OCD within a certain timeframe
  3. * if it is unsafe for them to participate in research
  4. * they have a current psychiatric disorder
  5. * a lifetime history of certain psychiatric disorders
  6. * are taking psychiatric medication or have in the past
  7. * have a parent or sibling who has been diagnosed with OCD
  8. * if it is unsafe for them to participate in research

Contacts and Locations

Study Contact

Amy Rapp, Ph.D.
CONTACT
212-241-5288
OCDResearch@mssm.edu

Principal Investigator

Amy Rapp, PhD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Icahn School of Medicine at Mount Sinai
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Amy Rapp, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-24
Study Completion Date2030-03-31

Study Record Updates

Study Start Date2025-07-24
Study Completion Date2030-03-31

Terms related to this study

Keywords Provided by Researchers

  • Obsessive Compulsive Disorder
  • Exposure and response prevention
  • Cognitive Behavioral Therapy
  • Electroencephalogram

Additional Relevant MeSH Terms

  • Obsessive Compulsive Disorder